Retraction notices

Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk

Type
Expression of concern
Notice date
2/20/2023 0:00
Journal
Immunology Letters
Publisher
Elsevier
Notice DOI
10.1016/j.imlet.2023.02.004
Original paper DOI
10.1016/j.imlet.2023.01.006

Reasons

Matching venue names

Name match only, not an authoritative journal identifier.